Clinical trials
Observational Granulomatous Disease, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2014 | 4 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 7 |
| Centre Hospitalier Universitaire de Liege | 1 |
| Ensoma | 1 |
| National Cancer Institute (NCI) | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| National Institute for Mother and Child Health Alessandrescu Rusescu | 1 |
| Paul Szabolcs | 1 |
| RTI International | 1 |
| Sanguine Biosciences | 1 |
| Shanghai Children's Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Granulomatous Disease, Chronic | 17 |
| Anemia, Sickle Cell | 3 |
| Chediak-Higashi Syndrome | 3 |
| Cystic Fibrosis | 3 |
| Inflammatory Bowel Diseases | 3 |
| Leukodystrophy, Metachromatic | 3 |
| Mucopolysaccharidosis I | 3 |
| Pseudohypoaldosteronism | 3 |
| Adrenoleukodystrophy | 2 |
| Anemia, Diamond-Blackfan | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.